Atomic AI

Atomic AI is a biotechnology company fusing machine learning with structural biology to unlock RNA drug discovery. Founded in 2017 by Raphael Townshend and based in San Francisco, the company builds ATOM-1, an AI foundation model that predicts the three-dimensional structure of RNA to enable the discovery and optimization of RNA-targeted small molecules and RNA-based medicines for previously undruggable targets, including certain cancers and neurodegenerative diseases. Atomic AI pairs its proprietary 3D RNA structure engine with large-scale in-house wet-lab assays. It is backed by Playground Global, 8VC, Greylock, and others. Atomic AI operates as a proprietary R&D drug-discovery platform and does not currently publish a public developer API, SDKs, or API documentation; this profile captures its public identity and web-surface signals for the API Evangelist network.

Atomic AI is profiled on the APIs.io network. Tagged areas include Company, Deep Tech, Biotechnology, Drug Discovery, and RNA.

Atomic AI’s developer surface includes engineering blog and 10 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.2/100 minimal ▬ flat Agent 4/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyDeep TechBiotechnologyDrug DiscoveryRNAMachine LearningLife SciencesArtificial Intelligence

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 11.2/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.4 / 20

Commercial Clarity 2.1 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 4/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 4 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/atomic-ai: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

WellKnown

WellKnown

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 7

The organization behind the API

Website

About

Blog

Careers

Partnering

LinkedIn

Twitter

Twitter

Scroll for all 7

Other 1

Properties that don't map to a standard resource type

Technology

Technology

Source (apis.yml)

aid: atomic-ai
name: Atomic AI
description: Atomic AI is a biotechnology company fusing machine learning with structural biology to unlock RNA drug discovery.
  Founded in 2017 by Raphael Townshend and based in San Francisco, the company builds ATOM-1, an AI foundation model that
  predicts the three-dimensional structure of RNA to enable the discovery and optimization of RNA-targeted small molecules
  and RNA-based medicines for previously undruggable targets, including certain cancers and neurodegenerative diseases. Atomic
  AI pairs its proprietary 3D RNA structure engine with large-scale in-house wet-lab assays. It is backed by Playground Global,
  8VC, Greylock, and others. Atomic AI operates as a proprietary R&D drug-discovery platform and does not currently publish
  a public developer API, SDKs, or API documentation; this profile captures its public identity and web-surface signals for
  the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/atomic-ai/refs/heads/main/apis.yml
x-type: company
x-source: greylock-portfolio
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
image: https://atomic.ai/wp-content/uploads/2024/04/logo-dark.svg
tags:
- Company
- Deep Tech
- Biotechnology
- Drug Discovery
- RNA
- Machine Learning
- Life Sciences
- Artificial Intelligence
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://atomic.ai/
- type: About
  url: https://atomic.ai/about/
- type: Technology
  url: https://atomic.ai/technology/
- type: Blog
  url: https://atomic.ai/news/
- type: Careers
  url: https://atomic.ai/careers/
- type: Partnering
  url: https://atomic.ai/partnering/
- type: PrivacyPolicy
  url: https://atomic.ai/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/atomic-ai-rna/
- type: Twitter
  url: https://twitter.com/AtomicAICo
- type: DomainSecurity
  url: security/atomic-ai-domain-security.yml
- type: WellKnown
  url: well-known/atomic-ai-well-known.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence